Blood Cancer UK
In research, Blood Cancer UK stands highest in Medicine (#4,130 of 17,978 worldwide), Health Sciences (#5,617 of 20,462 worldwide) and Life Sciences (#5,513 of 14,347 worldwide), over all time.
- World rank, all time
- #10,416 of 42,892
- Rank in United Kingdom
- #574 of 2,253
- Research works
- 562 ▲ 48% vs 2013–17
- Citations
- 26k 46.8 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 33% world 28%
What is Blood Cancer UK known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #4,130 of 17,978 | 28.5% | 351 | |
| Health SciencesDomain | #5,617 of 20,462 | 28.4% | 359 | |
| Life SciencesDomain | #5,513 of 14,347 | 23.9% | 173 |
Each strip is that field’s whole ranked pool, with the notch where Blood Cancer UK sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.9×
- Medicine 3.0×
- Immunology and Microbiology 1.6×
- Computer Science 1.1×
- Chemistry 0.9×
- Earth and Planetary Sciences 0.7×
- Environmental Science 0.7×
- Neuroscience 0.5×
- Materials Science 0.3×
- Health Professions 0.2×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.1×
- Social Sciences 0.1×
Who are the top researchers at Blood Cancer UK?
Ranked on the composite score, Leanne M. Wiedemann and JM Goldman lead among researchers whose main affiliation is Blood Cancer UK.
- 1 Leanne M. Wiedemann United Kingdom · #256,970 worldwide 120 citations · 18 works
- 2 JM Goldman United Kingdom · #308,075 worldwide 133 citations · 22 works
Which keywords describe research at Blood Cancer UK?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Mutation, BCR-ABL, Imatinib and Rituximab.
- Human Health
- Climate Change
- Public Health
- Immune Response
- Classification
- Deep Learning
- Genomic Aberrations
- Rituximab
- BCR-ABL
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Mutation
- Imatinib
- Chronic Lymphocytic Leukemia
- Therapeutic Targets
- Cancer
- Epidemiology
- Mortality
- Transcriptional Regulation
- Heat Waves
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 22 words, with their numbers
- Prognostic Factors6▲ 47×5 topics
- Hematopoietic Stem Cells4▲ 175×3 topics
- AML4▲ 252×1 topic
- Acute Myeloid Leukemia4▲ 252×1 topic
- Mutation3▲ 54×3 topics
- BCR-ABL3▲ 352×1 topic
- Imatinib3▲ 352×1 topic
- Rituximab2▲ 48×2 topics
- Chronic Lymphocytic Leukemia2▲ 137×1 topic
- Genomic Aberrations2▲ 137×1 topic
- Therapeutic Targets2▲ 42×2 topics
- Deep Learning2▲ 1.62×7 topics
- Cancer1▲ 3.5×15 topics
- Classification1▲ 9.5×3 topics
- Epidemiology1◆ 1.04×9 topics
- Immune Response1▲ 6.6×8 topics
- Mortality1▲ 6.6×3 topics
- Public Health1▲ 2.6×2 topics
- Transcriptional Regulation1▲ 24×4 topics
- Climate Change1▲ 1.36×2 topics
- Heat Waves1▲ 55×1 topic
- Human Health1▲ 22×1 topic
Which research topics does Blood Cancer UK publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Climate Change and Health Impacts.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 4 works
- 2 Chronic Myeloid Leukemia Treatments Hematology 3 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 2 works
- 4 Climate Change and Health Impacts Health, Toxicology and Mutagenesis 1 works
- 5 Eosinophilic Disorders and Syndromes Rheumatology 1 works
- 6 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
- 7 Protein Degradation and Inhibitors Molecular Biology 1 works
- 8 Hematopoietic Stem Cell Transplantation Hematology 1 works
- 9 Hemoglobinopathies and Related Disorders Genetics 1 works
- 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Blood Cancer UK's research output changed?
Output in 2018–2022 was 48% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.